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RNA-guided endonucleases (RGENs), derived from the prokaryotic adaptive immune system known as CRISPR/Cas,
enable targeted genome engineering in cells and organisms. RGENs are ribonucleoproteins that consist of guide RNA and
Cas9, a protein component originated from Streptococcus pyogenes. These enzymes cleave chromosomal DNA, whose se-
quence is complementary, to guide RNA in a targeted manner, producing site-specific DNA double-strand breaks (DSBs),
the repair of which gives rise to targeted genome modifications. Despite broad interest in RGEN-mediated genome editing,
these nucleases are limited by off-target mutations and unwanted chromosomal translocations associated with off-target
DNA cleavages. Here, we show that off-target effects of RGENs can be reduced below the detection limits of deep se-
quencing by choosing unique target sequences in the genome and modifying both guide RNA and Cas9. We found that
both the composition and structure of guide RNA can affect RGEN activities in cells to reduce off-target effects. RGENs
efficiently discriminated on-target sites from off-target sites that differ by two bases. Furthermore, exome sequencing
analysis showed that no off-target mutations were induced by two RGENs in four clonal populations of mutant cells. In
addition, paired Cas9 nickases, composed of D10A Cas9 and guide RNA, which generate two single-strand breaks (SSBs) or
nicks on different DNA strands, were highly specific in human cells, avoiding off-target mutations without sacrificing
genome-editing efficiency. Interestingly, paired nickases induced chromosomal deletions in a targeted manner without
causing unwanted translocations. Our results highlight the importance of choosing unique target sequences and opti-
mizing guide RNA and Cas9 to avoid or reduce RGEN-induced off-target mutations.
[Supplemental material is available for this article.]
Programmable nucleases, which include zinc finger nucleases
(ZFNs) (Bibikova et al. 2003; Urnov et al. 2005; Kim et al. 2011),
transcription activator-like effector (TALE) nucleases (TALENs)
(Miller et al. 2011; Kim et al. 2013a), and RNA-guided endonu-
cleases (RGENs) (Cho et al. 2013a; Cong et al. 2013; Hwang et al.
2013; Jinek et al. 2013; Mali et al. 2013b), enable efficient genome
editing in cells and organisms. These nucleases cleave chromo-
somal DNA in a targeted manner, producing site-specific DNA
double-strand breaks (DSBs), the repair of which via homologous
recombination (HR) or nonhomologous end-joining (NHEJ) leads
to gene disruption (Santiago et al. 2008; Sung et al. 2013), addition
(Moehle et al. 2007), correction (Urnov et al. 2005), and targeted
chromosomal rearrangements (Brunet et al. 2009; Lee et al. 2010,
2012). Programmable nuclease-based genome editing is now widely
used for making gene knockout/knock-in animals and plants as well
as genome-modified cell lines.
RGENs are derived from the type II CRISPR (clusters of regu-
larly interspaced palindromic repeats)/Cas (CRISPR-associated)
system, an adaptive immune response in bacteria and archaea
(Wiedenheft et al. 2012). Cas9, the protein component derived
from Streptococcus pyogenes, forms an active nuclease when com-
plexed with transactivating CRISPR RNA (tracrRNA) and CRISPR
RNA (crRNA) (Jinek et al. 2012), which are transcribed from the
CRISPR sequence encoded in the bacterial genome. This ribonu-
cleoprotein protects host cells from invading phages or plasmids
by recognizing and cleaving the DNA sequence corresponding to
the crRNA sequence. Recently, we and others have exploited this
system to induce site-specific DSBs, thereby modifying genomes in
a targeted manner in cells and organisms (Chang et al. 2013; Cho
et al. 2013a,b; Cong et al. 2013; Ding et al. 2013; Gratz et al. 2013;
Hwang et al. 2013; Jiang et al. 2013; Jinek et al. 2013; Mali et al.
2013b; Shen et al. 2013; Wang et al. 2013).
The specificity of an RGEN is determined by the 20-base pair
(bp) sequence in crRNA and the NGG trinucleotide (known as the
protospacer-adjacent motif [PAM]) that is recognized by Cas9.
Thus, an RGEN recognizes and cleaves a 22-bp target sequence,
which can be shown as 59-X20NGG-39, where X20 corresponds to
the crRNA sequence, and N is any base. Essential portions of crRNA
and tracrRNA can be linked to make single-guide RNA (sgRNA).
Although the 22-bp specificities of RGENs might be sufficient to
ensure targeted mutagenesis without off-target effects in higher
eukaryotic cells, a few careful studies duly raised concerns that
RGENs might cause collateral damage in the genome. Thus, Cas9
complexed with a crRNA that contains a one-base mismatch with
the target sequence can cleave the target DNA, albeit less effi-
ciently, both in vitro (Jinek et al. 2012) and in mammalian (Cong
et al. 2013) and bacterial cells (Jiang et al. 2013). RGENs tolerate
mismatches especially in the 59 upstream region, but not in the
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seed region of 6–11 nt that is immediately upstream of the PAM
sequence. Very recently, three groups independently showed that
RGENs indeed induce off-target mutations, even at sites that differ
by 5 nt from on-target sites in human cells (Fu et al. 2013; Hsu et al.
2013; Pattanayak et al. 2013).
We previously addressed this issue by using the T7 endonu-
clease I (T7E1) assay and showed that RGENs do not induce mu-
tations at potential off-target sites that are highly homologous to
on-target sites in human cells (Cho et al. 2013a); but due to its poor
sensitivity, this assay cannot detect off-target mutations that occur
at frequencies <1% (Kim et al. 2009). Here, we address this critical
issue more thoroughly by using deep sequencing, which can
measure off-target mutations that occur at frequencies ranging
from 0.01% to 0.1%. In addition, we isolated clonal populations of
cells that contained RGEN-induced mutations and investigated
whether these mutant cells harbor any off-target mutations in the
exome. Our results show that off-target effects of RGENs can be
reduced in human cells by choosing unique target sequences and
modifying the structure of crRNA or sgRNA. In addition, we report
that paired Cas9 nickases that generate two single-strand breaks
(SSBs) or nicks on different DNA strands are highly specific in
human cells, avoiding off-target mutations without sacrificing
genome-editing efficiency.
Results
Analysis of off-target effects of two RGENs at homologous sites
First, we searched for potential off-target sites in the human ge-
nome that might be recognized by two RGENs specific for the
C4BPB and CCR5 genes (Supplemental Table 1). We chose (1) those
sites (CCR5, Off1 to Off14 and C4BPB, Off1 to Off6 in Fig. 1) whose
sequences are conserved in the seed region but contain 3–8-base
mismatches in the 59 end; and (2) those sites (CCR5, Off15 to Off28
and C4BPB, Off7 to Off10) whose entire 22-bp sequences are most
similar to the target sequence and differ by up to 3 nt from the
target sequence. We measured the frequencies of small insertions/
deletions (indels) at the on-target site and putative off-target sites
using deep sequencing (Fig. 1A,B). The two RGENs induced indels
at frequencies of 75% (C4BPB) and 60% (CCR5) at corresponding
on-target sites in K562 cells. In sharp contrast, no indels were
detected at any measurable frequency (;0.01%) at any of the pu-
tative off-target sites we examined. Note that the CCR5 RGEN did
not induce any indels at two sites (Off15 and Off16) that each
contained a one-base mismatch in the 11-bp seed region and an-
other one-base mismatch in the upstream region. The Off17 site
contained a single-base mismatch in the 20-bp sequence corre-
sponding to the crRNA and another single-base mismatch in the
Figure 1. Mutation frequencies at on-target and potential off-target sites of the C4BPB- and CCR5-specific RGENs in K562 cells. (A,B) Cells were
transfected with crRNA, tracrRNA, and the Cas9 plasmid or the Cas9 plasmid alone (negative control). PCR amplicons that span the on-target site and
potential off-target sites were subjected to deep sequencing. Sequences that contained indels around the expected cleavage site were considered to be
RGEN-induced mutations. Mismatched bases are shown in red. The PAM sequence is shown in blue. (C ) In vitro cleavage assay of on-target or potential
off-target sequences by the CCR5-specific RGEN. Plasmids that contain putative off-target (upper) or hybrid (middle) sequences were digested with the
recombinant Cas9 protein complexed with crRNA and tracrRNA. Asterisks indicate cleaved DNA bands. (Bottom) DNA sequences of the on-target, off-
target, and hybrid sites.
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PAM. No indels were detected at this site, suggesting that PAM
recognition by Cas9 is also critical.
We also tested these two RGENs in another human cell line,
HeLa (Supplemental Fig. 1A,B), and found that these RGENs,
again, discriminated on-target sites from their most likely off-tar-
get sites by a factor of >10,000-fold. It is worth noting that off-
target mutations were not detected in either K562 or HeLa cells at
the C4BPB Off1 site, whose three mismatches are all located in the
upstream region. Taken together, these results suggest that the 59
upstream region outside the seed region in the target sequence also
contributes to the specificity of RGEN cleavage, and that RGENs
cannot efficiently cleave chromosomal DNA with mismatches of
two or more nucleotides, at least one of which occurs in the seed
region.
We then examined whether RGENs can differentially cleave
target and off-target DNA sequences in vitro. We incubated the
recombinant Cas9 protein/crRNA/tracrRNA complex with plas-
mids that contained either the CCR5 on-target sequence or off-
target sequences. Interestingly, the CCR5-specific RGEN displayed
a low level (<1%) of cleavage activity toward plasmids that con-
tained the off-target sequences (Fig. 1C), suggesting that RGENs
function less discriminatingly in vitro than they do in cells under
our experimental conditions. We also constructed and tested
plasmids that contained hybrid sequences with a single-base mis-
match (Off15-1, 15-2, 16-1, and 16-2 in Fig. 1C). These hybrid se-
quences were cleaved much more efficiently by the ribonucleo-
protein than were the off-target sequences with two-base
mismatches (Off15 and Off16). This result suggests that RGENs can
distinguish on-target sites from off-target sites with two-base mis-
matches but not those with a single-base mismatch.
Analysis of off-target effects of additional RGENs
To investigate off-target effects of RGENs further, we tested nine
additional RGENs that target the CCR5 gene. CCR5 is highly ho-
mologous to CCR2: Both genes encode G-protein-coupled che-
mokine receptors. We chose these additional sites so that the
RGENs would have off-target sites in the CCR2 gene that harbor
one- or two-base mismatches. We measured and compared muta-
tion frequencies of these RGENs at the CCR5 on-target and CCR2
off-target sites using deep sequencing. Three RGENs (#1, 2, and 3 in
Fig. 2) did not induce any off-target mutations at the CCR2 sites
that carried two-base mismatches: Indel frequencies were not
much different from those obtained with the empty vector con-
trol. One RGEN (#4) induced off-target mutations at the CCR2 site
that carried a one-base mismatch in the seed region and another
one-base mismatch in the upstream region at a frequency of 1.8%,
29-fold lower than the on-target mutation frequency.
We found, however, that RGENs cannot efficiently discrimi-
nate on-target sites from off-target sites that differ by a single base.
Thus, all four RGENs (#5–#8) induced indels at frequencies that
ranged from 1.6% to 43% at off-target sites that carried a single-
base mismatch either in the seed region or the upstream region.
Two RGENs (#5 and #8) were still able to discriminate on-target
sites from off-target sites with a single-base mismatch by a factor of
7.2- to 42-fold. One RGEN (#9) had an off-target site with a single-
base mismatch in the PAM. This RGEN discriminated the on-target
site from the off-target site by 490-fold, confirming, again, the
importance of PAM recognition by Cas9. These RGENs did not
induce any indels at several potential off-target sites identified in
other loci (Supplemental Table 2). Taken together, these results
suggest that RGENs can distinguish on-target sites from off-target
sites that differ by at least two bases, and that one could avoid or
minimize off-target effects of RGENs by choosing unique target
sites that do not have homologous sequences elsewhere in the
genome.
Exome sequencing analysis of RGEN-induced mutant clones
Next, we performed exome sequencing to identify RGEN-induced
off-target mutations, if any, on a genomic scale. Using limiting di-
lution, we isolated clonal populations of CCR5- or C4BPB-disrupted
Figure 2. Mutation frequencies at CCR5 on-target sites and CCR2 off-target sites. K562 cells were transfected with RGENs that target nine different sites.
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cells that contained RGEN-induced indels (Supplemental Fig. 2).
Of 37 or 47 clones, 29 (78%) or 35 (74%) had mutations in the
CCR5 or C4BPB genes, respectively. These high mutation fre-
quencies were comparable to those observed with deep sequencing
(Fig. 1A,B). Genomic DNA isolated from one C4BPB-disrupted
clone, two CCR5-disrupted clones, and wild-type K562 cells was
subjected to exome sequencing. Analysis of the exome sequence
data revealed a total of 308 indels present in the four clones, in-
cluding wild-type cells, compared to the reference genome—255 in
CCR5-disrupted clone #1, 246 in CCR5 clone #2, 233 in the C4BPB
clone, and 253 in the wild-type clone (the numbers are comparable
in these clones) (Supplemental Fig. 3A). Among these, 190 indels
were present in all four clones, including wild-type cells, and 74
indels were shared in at least two clones. These indels were ex-
cluded from further analysis. Ten indels were found only in the
wild-type clone, which suggests that the coverage of exome se-
quencing was not 100%. Likewise, 8, 9, and 17 indels were found
only in the C4BPB clone, CCR5 clone #1, and CCR5 clone #2, re-
spectively (Supplemental Table 3). We excluded 13 indels reported
in a public database (dbSNP build 130, NCBI), because they are
unlikely to result from RGEN-mediated DNA cleavages. We also
used Sanger and deep sequencing to show that most of these
‘‘clone-specific’’ indels are present even in wild-type cells. We then
searched for putative off-target sequences around the remaining
indels in the reference genome (Supplemental Table 4). Other than
the on-target mutations induced by the RGENs in these clones,
none of these indels were associated with potential off-target sites
(Supplemental Table 3; Methods). It is most likely that the indels
we found in gene-disrupted clones were the result of incomplete
coverage of exome sequencing (Clark et al. 2011). Exons are cap-
tured before sequencing, but this process covers only <90% of the
human exome. More than 10% of exons missed in wild-type cells
can be captured in mutant clones. To rule out the possibility that
the remaining sites are cleaved by off-target RGEN activity (al-
though their sequences are quite different from the on-target se-
quences), we incubated the RGENs with PCR amplicons that
contain the potential off-target sites in vitro. No cleavage was
detected (Supplemental Fig. 3B), suggesting that these sites are not
off-target sites. We note, however, that exome sequencing analysis
is limited by high false negative results (Karakoc et al. 2012): Off-
target indels present in clones might have been missed.
Guide RNA structure
Recently, three groups reported that RGENs had off-target effects in
human cells (Fu et al. 2013; Hsu et al. 2013; Pattanayak et al. 2013).
To our surprise, RGENs induced mutations efficiently at off-target
sites that differ by 3–5 nt from on-target sites. We noticed, how-
ever, that there were several differences between our RGENs and
those used by others. First, we used dualRNA, which is crRNA plus
tracrRNA, rather than single-guide RNA (sgRNA) that is composed
of essential portions of crRNA and tracrRNA. Second, we trans-
fected K562 cells (but not HeLa cells) with synthetic crRNA rather
than plasmids encoding crRNA. HeLa cells were transfected with
crRNA-encoding plasmids. Other groups used sgRNA-encoding
plasmids. Third, our guide RNA had two additional guanine nu-
cleotides at the 59 end, which are required for efficient transcrip-
tion by T7 polymerase in vitro. No such additional nucleotides
were included in the sgRNA used by others. Thus, the RNA
sequence of our guide RNA can be shown as 59-GGX20, whereas
59-GX19, in which X20 or GX19 corresponds to the 20-bp target
sequence, represents the sequence used by others. The first gua-
nine nucleotide is required for transcription by RNA polymerase in
cells. To test whether off-target RGEN effects can be attributed to
these differences, we chose four RGENs that induced off-target
mutations in human cells at high frequencies (Fu et al. 2013). First,
we compared our method of using in vitro transcribed dualRNA
with the method of transfecting sgRNA-encoding plasmids in
K562 cells and measured mutation frequencies at the on-target and
off-target sites via the T7E1 assay. Three RGENs showed compa-
rable mutation frequencies at on-target and off-target sites re-
gardless of the composition of guide RNA. Interestingly, one RGEN
(VEGFA site 1) did not induce indels at one validated off-target site,
which differs by 3 nt from the on-target site (termed OT1-11)
(Supplemental Fig. 4), when synthetic dualRNA was used. How-
ever, the synthetic dualRNA did not discriminate the other vali-
dated off-target site (OT1-3), which differs by 2 nt from the
on-target site.
Next, we tested whether the addition of two guanine nucle-
otides at the 59 end of sgRNA could make RGENs more specific by
comparing 59-GGX20 (or 59-GGGX19) sgRNA with 59-GX19 sgRNA.
Four GX19 sgRNAs complexed with Cas9 induced indels equally
efficiently at on-target and off-target sites, tolerating up to 4 nu-
cleotide mismatches. In sharp contrast, GGX20 sgRNAs discrimi-
nated off-target sites effectively. In fact, the T7E1 assay barely
detected RGEN-induced indels at six of the seven validated off-
target sites when we used the four GGX20 sgRNAs (Fig. 3). We
noticed, however, that two GGX20 sgRNAs (VEGFA sites 1 and 3)
were less active at on-target sites than were the corresponding
GX19 sgRNAs. These results show that the extra nucleotides at the
59 end can affect mutation frequencies at on-target and off-target
sites, perhaps by altering guide RNA stability, concentration, or
secondary structure. Our results suggest that three factors—the use
of synthetic guide RNA rather than guide RNA-encoding plasmids,
dualRNA rather than sgRNA, and GGX20 sgRNA rather than GX19
sgRNA—have cumulative effects on the discrimination of off-
target sites.
Paired Cas9 nickases
Previously, we showed that two zinc finger (ZF) nickases that
generate two adjacent SSBs or nicks on different DNA strands,
which give rise to a composite DSB, enable targeted mutagenesis
efficiently in human cells (Kim et al. 2012). In principle, SSBs
cannot be repaired by error-prone NHEJ but still trigger high fi-
delity homology-directed repair (HDR) or base excision repair; but
nickase-induced targeted mutagenesis via HDR is much less effi-
cient than is nuclease-induced mutagenesis (Ramirez et al. 2012;
Wang et al. 2012). We reasoned that paired Cas9 nickases would
produce composite DSBs, which trigger DNA repair via NHEJ or
HDR, leading to efficient mutagenesis (Fig. 4A). Furthermore,
paired nickases would double the specificity of Cas9-based genome
editing.
We first tested several Cas9 nucleases and nickases designed to
target sites in the AAVS1 locus (Fig. 4B) in vitro via fluorescent
capillary electrophoresis. Unlike Cas9 nucleases that cleaved both
strands of DNA substrates, Cas9 nickases composed of guide RNA
and a mutant form of Cas9 in which a catalytic aspartate residue is
changed to an alanine (D10A Cas9) cleaved only one strand, pro-
ducing site-specific nicks (Fig. 4C,D). Interestingly, however, some
nickases (AS1, AS2, AS3, and S6 in Fig. 5A) induced indels at target
sites in human cells, suggesting that nicks can be converted to
DSBs, albeit inefficiently, in vivo. Paired Cas9 nickases produc-
ing two adjacent nicks on different DNA strands yielded indels at
Cas9 RNA-guided nucleases and nickases
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frequencies that ranged from 14% to 91%, comparable to the ef-
fects of paired nucleases (Fig. 5A). In line with two recent reports
(Mali et al. 2013a; Ran et al. 2013), the repair of two nicks that
would produce 59 overhangs led to the formation of indels much
more frequently than those producing 39 overhangs at three ge-
nomic loci (Fig. 5A; Supplemental Fig. 5). In addition, paired nickases
enabled targeted genome editing via homology-directed repair
more efficiently than did single nickases (Supplemental Fig. 6).
We next measured mutation frequencies of paired nickases
and nucleases at off-target sites using deep sequencing. Cas9 nu-
cleases complexed with three sgRNAs induced off-target mutations
at six sites that differ by 1 or 2 nt from their corresponding on-
target sites with frequencies that ranged from 0.5% to 10% (Fig.
5B). In contrast, paired Cas9 nickases did not produce indels above
the detection limit of 0.1% at any of the six off-target sites. The S2
Off-1 site that differs by a single nucleotide at the first position in
the PAM (i.e., N in NGG) from its on-target site can be considered
as another on-target site. As expected, the Cas9 nuclease com-
plexed with the S2 sgRNA was equally efficient at this site and the
on-target site. In sharp contrast, D10A Cas9 complexed with the S2
and AS2 sgRNAs discriminated this site from the on-target site by
a factor of 270-fold. This paired nickase also discriminated the AS2
off-target sites (Off-1 and Off-9 in Fig. 5B) from the on-target site by
factors of 160-fold and 990-fold, respectively.
Chromosomal DNA splicing induced by paired Cas9 nickases
We and others have shown previously that two concurrent DSBs
produced by engineered nucleases, such as ZFNs and TALENs, can
promote large deletions of the intervening chromosomal segments
(Carlson et al. 2012). We tested whether two SSBs induced by
paired Cas9 nickases can also produce deletions in human cells. We
used PCR to detect deletion events and found that seven paired
nickases induced deletions of up to 1.1-kbp chromosomal seg-
ments as efficiently as paired Cas9 nucleases did (Fig. 6A,B). DNA
sequences of the PCR products confirmed the deletion events (Fig.
6C). Interestingly, the sgRNA-matching sequence remained intact
in two of seven deletion-specific PCR amplicons (underlined in Fig.
6C). In contrast, Cas9 nuclease pairs did not produce sequences
that contained intact target sites. This finding suggests that two
distant nicks were not converted to two separate DSBs to promote
deletions of the intervening chromosomal segment. In addition, it
is unlikely that two nicks separated by more than 100 bp can
produce a composite DSB with large overhangs under physiologi-
cal conditions because the melting temperature is very high. We
propose that two distant nicks are repaired by strand displacement
in a head-to-head direction, resulting in the formation of a DSB in
the middle, whose repair via NHEJ causes small deletions (Fig. 6D).
Because the two target sites remain intact during this process,
nickases can induce SSBs again, triggering the cycle repeatedly
until the target sites are deleted. This mechanism explains why two
offset nicks producing 59 overhangs but not those producing 39
overhangs induced indels efficiently at three loci.
We then investigated whether Cas9 nucleases and nickases
can induce unwanted chromosomal translocations that result
from NHEJ repair of on-target and off-target DNA cleavages (Fig.
7A). We were able to detect translocations induced by Cas9 nu-
cleases using PCR (Fig. 7B,C). No such PCR products were am-
plified using genomic DNA isolated from cells transfected with
the plasmids encoding the AS2 + S3 Cas9 nickase pair. This result
is in line with the fact that both AS2 and S3 nickases, unlike their
corresponding nucleases, did not produce indels at off-target sites
(Fig. 5B).
Discussion
Applications of engineered nucleases in research, biotechnology,
and medicine are hampered by their off-target effects. Both ZFNs
Figure 3. Comparison of guide RNA structure. Mutation frequencies of the RGENs reported in Fu et al. (2013) were measured at on-target and off-
target sites using the T7E1 assay. K562 cells were cotransfected with the Cas9-encoding plasmid and the plasmid encoding GX19 sgRNA or GGX20 sgRNA.
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and TALENs can induce mutations at off-target sites that are highly
homologous to on-target sites (Gabriel et al. 2011; Mussolino et al.
2011; Pattanayak et al. 2011). Too much off-target DNA cleavage
causes cellular toxicity (Kim et al. 2009). Furthermore, the repair of
off-target DSBs gives rise to unwanted chromosomal rearrange-
ments such as deletions, inversions, and translocations (Brunet
et al. 2009; Lee et al. 2010; Lee et al. 2012; Kim et al. 2013a). The
possibility that unknown off-target mutations may cause activa-
tion of oncogenes or inactivation of tumor suppressor genes is of
particular concern to researchers interested in using engineered
nucleases in gene or cell therapy.
RGENs are a new member in the growing family of pro-
grammable nucleases but are distinguished from the other
members, ZFNs and TALENs, in several respects. First, RGENs
function as monomers, whereas ZFNs and TALENs work in pairs
to cleave DNA. Use of an obligatory heterodimeric FokI nuclease
domain can make ZFNs and TALENs even more specific (Miller
et al. 2007; Szczepek et al. 2007). Second, the specificity of these
FokI-based nucleases can be enhanced by increasing the number
of zinc finger or TALE modules (Reyon et al. 2012). ZFNs and
TALENs that recognize DNA sequences longer than 30-bp are now
routinely used. In contrast, the specificity of RGENs is fixed to 22
bp. Third, zinc fingers (Bae et al. 2003) and TALEs (Boch et al.
2009) are derived from transcription factors that function in
higher eukaryotic organisms, whereas RGENs are derived from
prokaryotes whose genomes are ;1000-fold smaller than those of
higher eukarytotes. The specificity of RGENs might be limited to
the small size of prokaryotic genomes. These differences suggest
that RGENs may have more severe off-target effects than do ZFNs
and TALENs.
Unlike ZFNs and TALENs, whose DNA-targeting specificity is
determined solely by protein–DNA interactions that are often
context-dependent and unpredictable, RGENs recognize target
sites mostly by the simple Watson-Crick base-pairing rules. For
example, ZFNs induce off-target mutations at cryptic sites that
cannot be predicted based on sequence homology alone (Gabriel
et al. 2011). It is unlikely, however, that RGENs cleave off-target
DNA sequences whose recognition does not follow the base-pair-
ing rules. Thus, off-target sites of RGENs can be more reliably
predicted by sequence homology alone than are those of ZFNs or
TALENs. The question is then how many mismatches RGENs can
tolerate to trigger off-target DNA cleavage.
In this study, we showed that RGENs do indeed induce off-
target mutations at sites with a single-base mismatch. We found,
however, that RGENs efficiently discriminate on-target sites from
off-target sites that differ by only two bases. Furthermore, exome
sequencing showed that no off-target mutations were present in
four clonal populations of mutant cells. Our results suggest that
one could avoid or minimize off-target effects of RGENs by
choosing unique target sites that do not have any homologous
sequences elsewhere in the genome, a strategy we had used to
avoid off-target effects of TALENs (Kim et al. 2013a). We also found
that the structure and composition of guide RNA can be modified
to reduce off-target mutations. We cannot rule out the possibility
that the 11 RGENs we created in this study induce off-target mu-
tations at sites not examined here, which could be revealed by deep
Figure 4. In vitro DNA cleavage by Cas9 nickases. (A) Schematic overview of the Cas9 nuclease and the paired Cas9 nickase. The PAM sequences and
cleavage sites are shown in red. (B) Target sites in the human AAVS1 locus. The position of each target site is shown in red. (C ) Schematic overview of DNA
cleavage reactions. FAM dyes (shown in green) were linked to both 59 ends of the DNA substrate. (D) DSBs and SSBs analyzed using fluorescent capillary
electrophoresis. Fluorescently labeled DNA substrates were incubated with Cas9 nucleases or nickases before electrophoresis.
Cas9 RNA-guided nucleases and nickases
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sequencing at other less-homologous candidate sites or by whole
genome sequencing. In addition, in vitro selection of cleavage sites
(Pattanayak et al. 2011) or the IDLV capture approach (Gabriel
et al. 2011) used for the identification of ZFN off-target sites may
reveal cryptic sites cleaved by RGENs, although it is difficult to
imagine that RGENs recognize off-target sites that are not com-
plementary to crRNA sequences at an appreciable level. It is also
worth noting that RGENs cleave DNA much less discriminatingly
in vitro than they do in cells (Fig. 1C), limiting the in vitro selec-
tion method.
Since our initial submission, two groups reported that
paired Cas9 nickases can reduce off-target activity in human
cell lines (Mali et al. 2013a; Ran et al. 2013). Here, we also
showed that paired Cas9 nickases do not induce indels at off-
target sites at which their corresponding nucleases induce
mutations. Furthermore, we showed that paired Cas9 nickases
can induce large deletions of up to 1-kbp chromosomal seg-
ments in human cells and proposed a plausible mechanism that
is supported by mutant DNA sequences. Importantly, unlike
nucleases, paired nickases do not promote unwanted trans-
locations associated with off-target DNA cleavages. In principle,
paired nickases double the specificity of Cas9-mediated muta-
genesis and will broaden the utility of RNA-guided enzymes in
applications that require precise genome editing such as gene
and cell therapy. One caveat to this approach is that two highly
active sgRNAs are needed to make an efficient nickase pair,
limiting targetable sites. As shown in this and other studies, not
all sgRNAs are equally active. When single clones rather than
populations of cells are used for further studies or applications,
the choice of guide RNAs that represent unique sequences in
the genome and the use of optimized guide RNAs would suffice
to avoid off-target mutations associated with Cas9 nucleases.
We propose that both Cas9 nucleases and paired nickases are
powerful options that will facilitate precision genome editing
in cells and organisms.
Methods
Cell culture and transfection
K562 (ATCC, CCL-243) cells were grown in RPMI-1640 with 10%
FBS and a penicillin/streptomycin mix (100 units/mL and 100 mg/
mL, respectively). 2 3 106 K562 cells were transfected with 20 mg of
Cas9-encoding plasmid using the 4D-Nucleofector, SF Cell Line
4D-Nucleofector X Kit, Program FF-120 (Lonza) according to the
manufacturer’s protocol. After 24 h, 60 mg and 120 mg of in vitro
transcribed crRNA and tracrRNA, respectively, were transfected
into 1 3 106 K562 cells. Cells were collected 48 h after RNA
transfection and genomic DNA were isolated. Under these condi-
tions, RGENs showed the highest mutation frequencies.
HeLa cells (ATCC, CCL-2) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 100 units/
mL penicillin, 100 mg/mL streptomycin, 0.1 mM nonessential
amino acids, and 10% FBS. 0.8 3 105 HeLa cells were transfected
with Cas9-encoding plasmid (0.5 mg) and a tracrRNA /crRNA ex-
pression plasmid (0.5 mg) using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol.
Plasmids
The Cas9-coding plasmid used in this study was described pre-
viously (Cho et al. 2013a). In this vector, the Cas9 protein is
expressed under the control of the CMV promoter and is fused to
a peptide tag (NH2-GGSGPPKKKRKVYPYDVPDYA-COOH) con-
taining the HA epitope and a nuclear localization signal (NLS) at
the C terminus. Plasmids that encode tracrRNA, crRNA, and
sgRNA contained RNA sequences under the control of the U6
Figure 5. Comparison of Cas9 nuclease and nickase behavior. (A) On-target mutation frequencies associated with Cas9 nucleases (WT), nickases
(D10A), and paired nickases. Paired nickases that would produce 59 overhangs or 39 overhangs are indicated. (B) Analysis of off-target effects of Cas9
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promoter. The plasmid encoding D10A Cas9 was made by site-
directed mutagenesis.
Cas9 purification and in vitro DNA cleavage assay
The pET plasmid that encodes His-tagged Cas9 was transformed
into BL21(DE3). The expression of Cas9 and D10A Cas9 was in-
duced using 0.5 mM IPTG for 4 h at 25°C. The Cas9 protein was
purified using Ni-NTA agarose resin (Qiagen) and dialyzed against
20 mM HEPES (pH 7.5), 150 mM KCl, 1 mM DTT, and 10% glyc-
erol. More than 90% of the plasmid (350 ng) that contained the
CCR5 on-target sequence was cleaved within 1 h with 33 ng Cas9
protein, 10 ng tracrRNA, and 5 ng crRNA. In this study, we in-
cubated 350 ng target or off-target plasmid DNA or 200 ng PCR
amplicons with 1700 ng Cas9 protein, 500 ng tracrRNA, and
250 ng crRNA in a reaction volume of 20 mL in NEB buffer 3 for 1 h
at 37°C.
Fluorescent capillary electrophoresis
Substrate DNA for in vitro cleavage reactions was prepared by PCR
using 59-FAM labeled primers. The PCR products were purified and
used for in vitro DNA cleavage assays. The reaction products were
analyzed using fluorescent capillary electrophoresis.
RNA preparation
RNA was in vitro transcribed through run-off reactions by T7 RNA
polymerase. Templates for crRNA were generated by annealing two
complementary oligonuceotides (Supplemental Table 5). Tran-
scribed RNA was resolved on an 8% denaturing urea-PAGE gel.
RNA was recovered in nuclease-free water followed by phenol:
chloroform extraction, chloroform extraction, and ethanol pre-
cipitation. Purified RNA was quantified by spectrometry.
Targeted deep sequencing
The on-target and potential off-target regions were amplified using
Phusion polymerase (New England Biolabs) and used for library
construction. Equal amounts of the PCR amplicons were subjected
to paired-end read sequencing using Illumina MiSeq at Bio Medical
Laboratories. Insertions or deletions located around the RGEN
cleavage site (3 bp upstream of the PAM) were considered as a sig-
nature of NHEJ-mediated mutagenesis.
Figure 6. DNA splicing induced by paired Cas9 nickases. (A) The target sites of paired nickases in the human AAVS1 locus. The distances between the
AS2 site and each of the other sites are shown. Arrows indicate PCR primers. (B) Genomic deletions detected using PCR. Asterisks indicate deletion-specific
PCR products. (C ) DNA sequences of deletion-specific PCR products obtained using AS2 and L1 sgRNAs. Target site PAM sequences are shown in red, and
sgRNA-matching sequences are shown in capital letters. Intact sgRNA-matching sequences are underlined. (D) A schematic model of paired Cas9 nickase-
mediated chromosomal deletions. Newly synthesized DNA strands are shown in red.
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Exome sequencing
RGEN-induced mutant clones were isolated by limiting dilution
of populations of K562 cells transfected with the Cas9 plasmid
(20 mg), tracrRNA (120 mg), and crRNA (60 mg). Genomic DNA
from each clone was isolated using a G-DEXIIc kit (iNtRON Bio-
technology). Exome-captured libraries were constructed using
a TrueSeq Exome Enrichment kit (Illumina). PCR enriched li-
braries were subjected to Illumina HiSeq 2000 at Bio Medical
Laboratories. Exome sequence data were analyzed essentially as
described (Ousterout et al. 2013). Raw reads in FASTQ format were
aligned to the NCBI36/Hg18 reference genome using BWA-0.5.9.
PCR duplicates were removed using SAMtools-0.1.16. Single nu-
cleotide variants and indels were called using GATK-1.4. We then
verified variants in several ways: (1) Because engineered nucleases
rarely induce substitutions via error-prone NHEJ (Kim et al.
2013b), we excluded any single nucleotide variations; (2) shared
indels found in at least two clones were also excluded, except
those shared in the CCR5 #1 and CCR5 #2 clones; (3) naturally
occurring common indels were excluded by comparing to dbSNP
build 130; (4) we used Sanger and deep sequencing to exclude
indels present in wild-type K562 cells; and (5) we developed an
algorithm to search for putative off-target sequences around the
remaining indels in the reference genome. To quantify the simi-
larity or homology between the target sequence and query se-
quences, we considered a fixed ungapped alignment between
these sequences. Thus, we compared the 20-bp target sequence
(excluding the PAM) with a query sequence that spans from 23-bp
upstream to 23-bp downstream from the position of each indel
and counted the number (S) of matched bases. Because the
probability that one base of the query sequence would match the
corresponding base of the targeted sequence is 1/4, the P-value is
given as
P S $ kð Þ ¼ +20k
20!







where k is the number of matched bases.
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